CME Corner

 Clinician-Patient Shared Decision Making in MS: An Essential Step toward Better Outcomes

A 3-Part CME/CNE-certified Series

The management of MS is increasingly challenging due to its heterogeneous pathology, the wide variation in the clinical course for each patient, an increasing number of therapeutic options, and evolving best practices. Neurologists and other clinicians on the multidisciplinary MS care team have the opportunity to improve outcomes for patients with MS by supporting the tailored use of disease-modifying therapies (DMTs) and engaging patients more fully in their own care. This CME/CNE-certified series will provide expert insight, practical strategies, and case-based discussions so that learners can appropriately integrate shared decision making into their practices.

Target audience:
This activity is designed for neurologists, mental health specialists, physician assistants (PAs), and nurse practitioners (NPs) as well as nurses and other professionals who care for patients and families affected by MS.

newsletter Motivational Interviewing to Support Shared Decision Making in MS
First Question: Should I Start Treatment?


Shared Decision Making in Selecting Initial MS Disease-Modifying Therapy
Next Question: Which Disease-Modifying Therapy Should I Try First?


newsletter Shared Decision Making at the Crossroads: Adjusting MS Therapy
Next Question: When Is it Time to Adjust Therapy?



Barbara S. Giesser, MD
Professor of Clinical Neurology
Medical Director, Multiple Sclerosis Achievement Center
Clinical Director, Multiple Sclerosis Program
David Geffen School of Medicine at UCLA
Los Angeles, CA

Lawrence M. Samkoff, MD
Associate Professor of Neurology
Attending Neurologist
Neuroimmunology Unit
Department of Neurology
University of Rochester Medical Center
Rochester, NY

Kirstin Nygren, MSN, NP, MSCN
Nurse Practitioner,
Multiple Sclerosis Clinic
Department of Neurology
David Geffen School of Medicine at UCLA
Los Angeles, CA 




Main Menu